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Structure of the C3b Binding Site of CR1 (CD35),
the Immune Adherence Receptor
C3b. The resulting bound C3 fragments are ligands for
other complement receptors. CR1 is expressed by most
blood cells and its function varies depending upon cell
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type. CR1 on erythrocytes binds and processes immuneDusan Uhrin,1 John P. Atkinson,2
complexes and transfers them to the liver and spleen.and Paul N. Barlow1,3
On granulocytes and monocytes/macrophages, CR11Edinburgh Protein Interaction Centre
mediates attachment and ingestion of complement-Joseph Black Chemistry Building
coated targets. On B lymphocytes and follicular-den-University of Edinburgh
dritic cells, CR1 facilitates localization of complement-West Mains Road
coated antigens to immunocompetent cells. Of recentEdinburgh EH9 3JR
interest is the interaction between the C3b binding siteUnited Kingdom
of CR1 and a major adhesin of Plasmodium falciparum-2 Division of Rheumatology
infected erythrocytes (Rowe et al., 1997, 2000); thisDepartment of Medicine
interaction leads to rosetting between infected andWashington University School of Medicine
uninfected erythrocytes, a phenomenon correlated withSt. Louis, Missouri 63110
severe malaria.
The N-terminal extracellular portion of CR1 is com-
posed of 30 repeats of 59–72 amino acids (aa) (KlicksteinSummary
et al., 1987, 1988; Hourcade et al., 1988). These fold into
modules, linked by nonconserved sequences of four toComplement receptor type 1 (CR1 or CD35) is a multi-
eight aa. Homologous modules are prevalent amongple modular protein that mediates the immune adher-
the regulators of complement activation (RCA) familyence phenomenon, a fundamental event for destroying
(Liszewski and Atkinson, 1998) and are known as com-microbes and initiating an immunological response. It
plement control protein modules (CCPs) (also known asfulfills this role through binding C3b/C4b-opsonized
sushi domains and short consensus repeats) (Reid andforeign antigens. The structure of the principal C3b/
Day, 1988). Apart from four consensus Cys and a con-C4b binding site (residues 901–1095) of CR1 is re-
served Trp, significant sequence diversity is presentported, revealing three complement control protein
among CCP sequences, and insertions and deletionsmodules (modules 15–17) in an extended head-to-tail
are commonplace. Three-dimensional structures havearrangement with flexibility at the 16-17 junction.
been solved of12 CCPs (Kirkitadze and Barlow, 2001;Structure-guided mutagenesis identified a positively
Szakonyi et al., 2001) but not of any of the CR1 CCPs.charged surface region on module 15 that is critical
Despite a broadly similar structural framework, therefor C4b binding. This patch, together with basic side
are variations in loops and turns. These contribute tochains of module 16 exposed on the same face of CR1,
significant and functionally critical differences in the ar-is required for C3b binding. These studies reveal the
rangement of adjacent CCPs.initial structural details of one of the first receptor-
CR1 has two functionally distinct sites (Klickstein etligand interactions to be identified in immunobiology.
al., 1988; Krych et al., 1991). Site 1 (CCPs 1–3) binds
mainly C4b and has convertase decay accelerating ac-Introduction
tivity (DAA), while two nearly identical copies of site 2
(localized to modules 8–10 and 15–17; Figure 1) bind
Immune adherence, first described at the beginning of
C3b and C4b and have factor I-cofactor activity (CA)
the 20th century, was rediscovered in the 1950s (Nelson,
with respect to both proteins (Krych et al., 1991, 1994,
1953, 1963). It refers to binding of serum-exposed parti- 1998; Krych-Goldberg et al., 1999). In prior homologous
cles to blood cells, which is a fundamental event for substitution-mutagenesis studies of sites 1 and 2, some
initiating and promoting the destruction of microbes and single aa substitutions reduced binding of one or both
for an immunological response. This interaction is de- ligands (Krych et al., 1991, 1994, 1998; Krych-Goldberg
pendent on the coating of the antigenic particle with et al., 1999). In some cases reciprocal changes in sites
complement and recognition by a factor on the erythro- 1 and 2 led to a loss of function at one site and to a
cyte surface—the immune adherence receptor. gain of the same function at the other site. Although key
Activation of complement leads to deposition of C4b amino acids for DAA and CA were identified, a complex
and C3b on a target. Complement receptor type 1 (CR1, picture emerged. Moreover, the results of homologous
CD35) (reviewed Krych-Goldberg and Atkinson, 2001) substitution mutagenesis did not identify potential con-
binds to these immobilized ligands and is the immune tact points in the first module of either site and offered
adherence receptor. In addition, CR1 regulates further no explanation as to how these CCPs participate in
complement activation by accelerating the decay of key binding. Lack of a 3D structure of CR1, or of any mam-
proteolytic complexes, the C3 and C5 convertases, and malian C3b/C4b binding protein, has thus hampered
by serving as a cofactor for limited cleavage of C4b and further understanding.
The 3D structure of an individual CCP is difficult to
model with confidence due to sequence variation, and3 Correspondence: barlow@chem.ed.ac.uk
4 These authors contributed equally to this work. the orientation and flexibility of neighboring CCPs with
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Figure 1. NMR-Derived Structures of Site 2 from CR1
(A) Location of CCPs 8 and 15 (red), CCPs 9 and 16 (cyan), and CCPs 3, 10, and 17 (blue) in CR1.
(B) Backbone overlays of NMR-derived structures. In each case 24 structures are overlaid on C atoms of CCP 16 (mean structure).
(C) Distribution of tilt, twist, and skew angles among the two ensembles of structures. Arrows show mean angles.
(D) The structure (backbone; stereopair) closest to the mean of the CR115,16 structures (red) overlaid on module 16 (C’s) of the equivalent
structure from the CR116,17 ensemble (blue).
respect to one another vary considerably and are unpre- ensembles of structures calculated for these overlap-
ping module pairs (structural statistics, Table 1). Thedictable. Therefore, to understand the structural basis
root mean square deviation (rmsd) of the C atoms fromof immune adherence and of complement control, it is
the respective mean structures is plotted for each pairnecessary to solve experimentally the 3D structures of
in Figure 2 along with the number of nuclear Overhauserthe triple-CCP functional sites. We now report the solu-
effects (NOEs) per residue. Values of rmsd were basedtion structure of CCPs 15, 16, and 17 of human CR1
on overlaying each module in turn and excluding disor-(CR115–17, site 2). The structure has allowed rational-
dered residues (i.e., with low 1H,15N-NOE). Overall rmsdization of an extensive body of mutagenesis and design
values (Table 1) indicate that individual modules areof new mutagenesis experiments. In the absence of di-
quite well defined by the data.rect structural studies of the C3b/CR1 interaction, these
There are no significant differences in CCP 15 chemi-data provide the most detailed understanding so far of
cal shifts (s) when the 15,16 pair is compared tothe molecular basis of immune adherence, some 100
CR115–17 (data not shown). Context-dependent dif-years after its discovery.
ferences in the s of CCP 17 (i.e., in CR115–17 versus
in CR116,17) arise only from the nonidentical C termini
Results of the two fragments; no changes are attributable to the
presence or absence of CCP 15. Thus, CCPs within site
Nuclear magnetic resonance (NMR) data collected on 2 are arranged such that CCPs 15 and 17 are not in direct
CR115–17 permitted assignment of 90% of back- contact, consistent with previous studies (Kirkitadze et
bone 15N, 13C, 13C(O), and 13C resonances. The sensitiv- al., 1999a, 1999b). Comparison of the s of module 16
ity of side chain experiments collected on samples of in CR115,16 ((15)16), in CR116,17, (16(17)), and in
CR115–17 was, however, too poor for complete as- CR115–17 ((15)16(17)) shows that CCP 16 exhibits con-
signment. To circumvent this, the two overlapping mod- text-dependent changes in s near (in space) its N and
ule pairs (CR115,16 and CR116,17) were investi- C termini, but not elsewhere. The structures of modules
gated. These proteins were fully assigned and yielded (15)16 and 16(17) are not significantly different (Figures 1
NOESY spectra suitable for structure determination. and 2); the rmsd is 0.58 A˚ (for the C overlay), excluding
disordered residues. These observations all imply thatFigure 1 shows backbone overlays, on CCP 16, of the
Structure of CR1 Site 2
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Table 1. Structural Statistics for the 24 Lowest Energy Structures
CR115,16 CR116,17
Total unambiguous NOEs 2869 2331
Total ambiguous NOEs 455 226
Hydrogen bonds 29 25
For unambiguous NOEs
Sequential 664 564
Short-range (2|ij|4) 194 146
Long-range (|ij|4) 786 563
Intermodule 13 4
Intralinker 74 69
From 17 to 16,17 linker – 29
From 16 to 16,17 linker – 39
From 16 to 15,16 linker 46 –
From 15 to 15,16 linker 48 –
For ambiguous NOEs
Sequential 148 69
Short range (2|ij|4) 36 25
Long range (|ij|4) 225 93
Intermodule ambiguous NOEs 1 0
Intralinker ambiguous NOEs 17 3
From 17 to 16,17 linker – 1
From 16 to 16,17 linker – 8
From 16 to 15,16 linker 12 –
From 15 to 15,16 linker 28 –
Total (all structures) NOE violations  0.5 33 44
Rmsds for ensemble of 24a  SD
NOE (A˚) 0.0329  0.0026 0.0370  0.0034
Bond lengths (A˚) 0.0022  0.0001 0.0021  0.0001
Bond angles () 0.3936  0.0173 0.3734  0.0233
Rmsds for representative structurea
NOE (A˚) 0.0034 0.0037
Bond lengths (A˚) 0.0022 0.0020
Bond angles () 0.3933 0.3613
Percent of residues in regions of
Ramachandran plot
Most favored 67.9 60.0
Additionally allowed 24.8 28.2
Generously allowed 5.5 5.5
Root mean square deviationsb 15 16 17
Backbone atoms C, N, CO 0.677 0.734 1.103
C only 0.687 0.759 1.148
a Representative structure is closest to the mean of the appropriate ensemble of 24 structures.
b From Cys1 to Cys4, excluding residues (1) with heteronuclear NOE values less than one SD lower than mean and (2) for which relaxation
data were unavailable. Average of (15)16 and 16(17) values shown for CCP 16.
the structure of CR115–17 can be reconstructed by Cys(I)-Cys(III) and Cys(II)-Cys(IV), are well spaced, and
the consensus Trp and other conserved residues con-superimposing the structures of (15)16 and 16(17) (see Fig-
ure 1). To create the model, structures closest to the tribute to a hydrophobic core within each module.
Residues (Figure 2) with high 15N T1 values, high T2s,mean of each of the two ensembles of calculated mod-
ule-pair structures were used as input for the program and negative 1H,15N NOEs occur at the N termini of both
module pairs, indicating that these regions (before Cys(I)Modeller (Sali and Blundell, 1993; see Experimental Pro-
cedures). of the first module) are highly mobile on the ps–ns time-
scale. The residues at the N terminus of CCP 16 becomeEach of the three CCPs of site 2 has a structure con-
sisting of extended regions and antiparallel  strands, significantly less mobile upon attachment of CCP 15.
Residues at the C terminus of CCP (15)16 and of CCP 17connected by loops. Extended regions classified (Pro-
motif [Hutchinson and Thornton, 1996]) as  strands have less ps–ns motion. In general, dips in the plot of
1H,15N NOEs are accompanied by longer T1s and T2s andin 50% of the ensemble are shown in Figure 3. The
extended regions (whether or not categorized as  correspond to loops consistent with the flexibility of
these regions. Some residues were deemed to be under-strands) in each module were denoted A–H (only 
strands are labeled in Figure 3). Each module has an going slower scale (	s–ms) motion (on the basis of appli-
cation of the criteria of Barbato et al., 1992; Figure 2).elongated shape, with a long axis running between the
N and C termini. The strands are, for the most part, The CCPs are assembled in head-to-tail fashion (Fig-
ure 3). The mutual orientation of CCPs 15 and 16 isaligned with the long axis, and connecting loops are
close to the intermodular interfaces. The disulphides, determined experimentally by a network of 13 unambig-
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Figure 3. Modules and Intermodular Junc-
tions of Site 2
In the center is shown a representation
(Kraulis, 1991) of the CR115–17; same view
as in Figure 1. Eight side chains are shown
in each module; parenthetical number
(3, 
3,
5) indicates position relative to the
conserved Gly at the N terminus of strand D.
On the left, schematics illustrate occurrence
(red lines) of intermodular and module-linker
NOEs within the 15,16 (bottom) and 16,17
junctions. Dotted lines indicate one NOE,
solid lines indicate more than one; thickness
of line is proportional to number of NOEs.
On the right are shown details of junctions
(same view as on left) with backbone trace
in red (15,16) or blue (16,17) and side chains
atoms colored green, C; blue, N; red, O; and
yellow, S.
uously assigned NOEs between the bodies of the mod- Strand F of CCP 16 approaches the DE loop (i.e., loop
between strands D and E) of CCP 15, and a CH3 ofules and a total of 134 NOEs (94 of them unambiguously
assigned) between the linker and the modules (Figure 3, Leu1006 contacts Glu935.
The 16-17 junction is less well defined by distanceTable 1). Analysis of 55 1H-15N residual dipolar couplings
measured for CR115,16 in hexanol/cetylpyridinium restraints between modules (Figure 3, Table 1). The pre-
ferred orientation that emerges from the calculation isbromide medium (data not shown) are compatible with
CCPs 15 and 16 having the same alignment tensor, determined by only 4 intermodular NOEs and by 68 un-
ambiguous and 9 ambiguous NOEs between the linkerwhich is evidence in support of a defined association
between modules. Moreover, the dipolar couplings are and the two modules. This junction is more open with
few hydrophobic contacts. The side chain of Arg995 inalso consistent with the relative orientations seen in the
ensemble of structures (Figure 3) derived from NOEs strand E of CCP 16 could contact residues in the FG
loop of CCP 17, but the latter is flexible. The first twoand J couplings. In the 15-16 junction, the carbonyl
oxygen of linker residue Lys961 has an inferred H bond residues of the 16-17 linker (aa 1021 and 1022) are
closely associated with CCP 16, but the side chainsto the NH of Val982 (in the CD loop of CCP 16), and an
H bond from the NH of Lys961 to the backbone carbonyl of the next two residues do not form part of a larger
hydrophobic pocket as seen in other junctions. Givenoxygen of Glu935 (in CCP 15) was inferred. Side chains
of linker residues Arg960 and Lys961 are in van der the relatively small number of NOEs defining the 16-17
junction, the poor definition (Figure 1) in intermodularWaals contact with Tyr936 and Tyr937, respectively, of
CCP 15. The side chains of both these linker residues orientation may reflect flexibility between CCPs 16 and
17. The 1H-15N NOEs of amides in the 16-17 linker arealso contact the CH3 protons of Val982 (module 16).
Figure 2. Experimental NMR-Derived Data
The top graph summarizes the data used for the structure calculations and the precision of the calculated structures. The number of distance
restraints per residue are shown (bars, left-hand scale): sequential (residue i  residue i
1) in dark gray, short range (i(i
(5)) in green, and
long range (i(i
(4)) in light gray. Root-mean-square deviations (rmsds) of the C coordinates of well-ordered residues in each module from
its mean structure are plotted (o, lines, right-hand scale; 15,16 [red] and 16,17 [blue]) as is the C rmsd between the mean structures of (15)16
and 16(17) (black).
Lower three graphs: 15N T1, heteronuclear NOEs, and 15N T2 for 15,16 (red) and 16,17 (blue) versus residue number. Mean  SD is shown for
each module by a horizontal black line (dotted for 16,17). Secondary structure is indicated. In the T2 panel, red (15,16) and blue (16,17) squares
indicate residues mobile on 	s–ms timescale (based on 15N T1 and T2).
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similar to those for the 15-16 linker. They do not indicate Structure of Site 2
The structure of functional site 2 (CCPs 15, 16, and 17)flexibility on the ps–ns timescale, and only Ile1023 is
flexible on the 	s–ms timescale but CCP 16-CCP 17 of CR1, which is the main locus of C3b binding, was
determined by combining solution structures of theflexibility could still be in the order of 108 s1.
Intermodular orientations are characterized by tilt, overlapping CCP pairs, CR115,16 and 16,17, and vali-
dated by a chemical shift comparison with CR115–17.twist, and skew (Barlow et al., 1993; Bork et al., 1996).
In both junctions, the tilt angles within the ensemble of In determining the structure of CR115–17, the struc-
ture of CR18–10 (identical bar three residues) has alsocalculated structures are 20–30; the tilt of CCP 17
compared to CCP 15 (in the reconstruction) is 39. The been effectively solved, as has the structure of module
3 (Figure 1). Further, because CCPs 1 and 2 are 61%twist angle at the 15,16 junction is close to 180; the
twist at the 16,17 junction is closer to 90, and the twist identical to CCPs 15 and 16, respectively, the current
results provide a reliable basis for the modeling by ho-of CCP 17 compared to CCP 15 (in the reconstruction)
is280. Consequently, the three modules trace a gentle mology of these CCPs of site 1.
A network of 107 long-range NOEs involving five resi-curve (Figure 3), and equivalent regions of the three
modules such as the hypervariable loops (Wiles et al., dues in the DE loop of module 15, all residues of the
linker, and four residues in two loops of module 16 pro-1997) face in different directions. Skew angles are less
well defined, especially at the 16,17 junction. The elon- vide an experimentally derived definition of the relative
orientations of modules 15 and 16 that is supported bygated shape of site 2 results in a large solvent-exposed
surface area with potential for extensive contacts with residual dipolar couplings. Therefore, this junction must
be relatively rigid. Fewer NOEs provide experimentalbinding partners.
Since despite extensive mutagenesis experiments no validation of the 16-17 orientation, and in agreement
with previous work (Kirkitadze et al., 1999a, 1999b), thisstrong candidates for key contact points had previously
been identified in CCP 15, the NMR-derived structure junction is likely to be less tight than the 15-16 one.
Residues within the 16-17 linking sequence do not haveof CR1 site 2 was utilized to perform a search for critical
residues in this module. Based on previous studies significantly different relaxation properties to the 15-16
linker. Nevertheless, 108 s motion of CCP 16 relative(Krych et al., 1994, 1998), residues in CCP 15 lying on
the same face of the triple module as functionally critical to CCP 17 cannot be excluded (Copie et al., 1998) and
would be consistent with the small intermodular inter-Asn1009 and Lys1016 of CCP 16 were considered candi-
dates. Among these, residues with basic side chains face and the lack of definition of the skew angle among
the ensembles of NMR-derived structures. Evidence ofwere selected for mutagenesis because it has been
shown that acidic residues of C3b are involved in binding flexibility between modules has been found in studies
of MCP (Casasnovas et al., 1999), factor H (Barlow etCR1 (Oran and Isenman, 1999). A patch of basic side
chains in module 15—Lys912 and Lys914 in strand B al., 1993), and VCP (in solution) (Henderson et al., 2001)
but not in the crystal structures of VCP (Murthy et al.,and Arg933 at the end of strand D—lie on this “front”
face (Figure 4). Changing all three to Glu abrogated C4b 2001) or -2-glycoprotein I (B2GPI) (Bouma et al., 1999;
Schwarzenbacher et al., 1999).binding and significantly reduced C3b binding (Figure
5). When these three mutations of module 15 were com-
bined with K1016E in CCP 16, C3b binding was further Comparison with Structures of Other CCPs
reduced, even at low salt. Another surface Lys (964) on The structure of site 2 is elongated with an axial ratio
CCP 16 was observed to lie roughly equidistant from of 5:1, consistent with hydrodynamic studies (Kirki-
Asn1009 and Lys1016 and on the left-hand side of the tadze et al., 1999c). Anisotropic tumbling might explain
front face as viewed in Figure 4. Charge reversal here the broad NMR resonances that precluded direct deter-
(K964E) enhanced the effects of the combined muta- mination of the CR115–17 structure. The CCPs each
tions K912E, K914E, and R933E in CCP 15 to a similar have a broadly similar structure to their counterparts in
extent as the K1016E mutation. When all five basic side VCP (modules 1–3) and MCP (modules 1 and 2). The
chains (Lys912, Lys914, and Arg933 in module 15 and closeness (rmsd of 1.1 A˚ over backbone atoms of 58
Lys964 and Lys1016 in module 16) were mutated to Glu, residues) between the structures of CCP 16 of CR1 and
C3b binding was reduced to 35% (low-salt) or 10% CCP 2 of MCP (22 sequence identities, 8 conservative
(100 mM salt) (Figure 5). An assay for cofactor activity replacements) is surprising, since there are several non-
for C3b showed that in each case cofactor activity paral- conserved prolines toward the N terminus and these
leled that of ligand binding. two CCPs have no known functional similarities. On the
other hand, a comparison of CR1’s CCP 16 and CCP 2
of VCP (22 identities, 7 conservative replacements) givesDiscussion
a relatively poor rmsd of 2.0 A˚ over 43 residues. The
best rmsd that can be achieved between MCP1 andAn understanding of the mechanism of interaction be-
tween CR1, which is the immune adherence receptor, CR115 (15 identities, 4 conservative replacements) is
2.0 A˚ over 27 residues. These comparisons illustrate theand C3 is important since it is the basis of some of the
most ancient and fundamental of immunological pro- importance of experimental structure determination of
CCPs despite the availability of homologous structures.cesses. Immune adherence allows C3 to act as nature’s
adjuvant for the humoral immune response and to carry However, the most important aspect of the current work
lies in the elucidation of intermodular orientations, sinceout its roles in facilitating phagocytosis and in the pro-
cessing of immune complexes. Binding of CR1 to C3b/ these cannot be predicted with reliability by homology.
A range of configurations of neighboring CCPs haveC4b is also critical to the complement system.
Structure of CR1 Site 2
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Figure 4. Mutations Mapped onto Surface of
Site 2
Left: surface of CR115–17 using color
scheme (red, 15; cyan, 16; blue, 17), except
where mutagenesis yielded no significant
loss of C3b (iC3) binding or C4b binding
(black), some loss of C3b (iC3) binding (aa
937, 1053) or C4b binding (aa 927, 929, 1046)
(yellow), or major loss of C3b and/or C4b
binding (white). Single asterisk indicates resi-
dues that, when incorporated at their equiva-
lent positions in site 1 (i.e., D109N, N29K, and
T14K), caused gain of C3b binding. Double
asterisk indicates two residues (Y27S/G79D)
that confer C3b binding activity when simul-
taneously inserted at their equivalent posi-
tions in site 1.
Right: same features but rotated (about verti-
cal axis) by 180.
been observed in the 3D structures solved to date. In structures have been determined, will be highly similar
in structure to those of site 2 (with the exception ofVCP, modules 3 and 4 have a relatively large tilt angle
(Wiles et al., 1997; Murthy et al., 2001), as do MCP mod- some flexible loops and localized changes in strands B
and C and the GH bulge associated with nonconservedules 1 and 2 (Casasnovas et al., 1999), while CCPs 1
and 2 of CR2 exhibit a unique side-to-side packing (Sza- Gly and Pro residues). What about the intermodular junc-
tions of site 1? Several of the amino acids important inkonyi et al., 2001). The most common arrangement is
head-to-tail, as seen in B2GPI (Bouma et al., 1999; the interface between CCPs 15 and 16 are conserved,
or conservatively replaced, in site 1. However, Tyr937Schwarzenbacher et al., 1999), factor H (modules 15 and
16; Barlow et al., 1993), VCP modules 1 and 2 (Murthy et is replaced by a Ser, and Glu935 is replaced by a Gly.
Thus, the 1,2 interface is probably different from theal., 2001), and now in CR1. It is noteworthy, however,
that angles of tilt, twist, and skew are different in each 15,16 interface, in agreement with the different thermo-
dynamic unfolding profiles of site 1 versus site 2 (Kirki-case. For example, the MCP1, 2 junction is more
kinked (tilt equals 75) than the 15,16 one, and there is tadze et al., 1999a; Clark et al., 1996). It is possible that
the looser 16,17 junction resembles that between CCPslittle in common between the 1,2 junction of VCP and
the 15,16 junction of CR1, or between the 2,3 junction of 2 and 3, since the DE regions of CCPs 16 and 2 are
similar and the linker sequences and the sequences ofVCP and the 16,17 junction of CR1, resulting in different
intermodular orientations. the FG and CD regions of CCPs 17 and 3 are identical.
Mutagenesis and Functional ImplicationsImplications for the Structure of Site 1 (CCPs 1–3)
Although in general CCPs exhibit high sequence diver- The availability of a 3D structure of the complete, func-
tional site 2 of CR1 allows rationalization of extensivesity, the CCPs of site 2 of CR1 are similar to the CCPs
(1–3) of its site 1. Comparison of CCP 15 with CCP 1 mutagenesis experiments. Previously, homology-based
models have been used to explain mutagenesis data(31 identities, 6 conservative replacements), CCP 16
with CCP 2 (42 identities, 4 conservative replacements), (e.g., Kuttner-Kondo et al., 2001; Liszewski et al., 2000;
Villoutreix et al., 1998), since experimentally determinedand CCP 3 with CCP 17 (two replacements) indicates
that the three individual modules of site 1, for which no structures were unavailable. The cocrystallization of
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effect on its biological activity (Figure 4). Some of the
substitutions were conservative (Q903N, D906E, and
I1012L), while others were not (e.g., P954A, T987K, and
V1049S). This observation supports the notion that the
CCP consensus residues provide a structural framework
that is very tolerant of amino acid substitutions else-
where in the sequence. Therefore, mutations of noncon-
sensus amino acids that have side chains known to be
exposed at the surface and not involved in intramolecu-
lar module-module contacts are unlikely to significantly
disturb the structure of the protein. The implication is
that where such mutations abrogate function, they are
likely to be in direct contact with binding partners.
In the case of module 15, one face (“front” in Figure
4) carries several side chains that contribute to C3b
binding and (especially) C4b binding, while no such resi-
dues have so far been identified on the “back” face.
Module 16 is oriented in a relatively well-defined manner
with respect to module 15, and N1009, which resides in
the flexible FG loop of module 16, lies on the same front
face as CCP 15 residues that are critical for binding. It
is interesting that the substitution of several of these
amino acids (N1009, K914, and K929) for their equiva-
lents in site 1 causes site 1 to gain significantly in its
ability to bind C3b (Krych et al., 1998; Krych-Goldberg
et al., 1999). Other CCP 16 residues implicated by muta-
genesis also lie on this front face, while no such residues
have so far been detected on the back face (Figure 4).
Furthermore, the back face of module 16 carries the
glycosylation site, N987 (mutated to Thr in the NMR
sample, hence T987 in Figure 4); glycosylation does
not influence C3b or C4b binding. Therefore, it appears
probable that the front face of site 2 contacts C3b andFigure 5. Ligand Binding by Charge-Reverse Mutants in Site 2
C4b. The most dramatic results were obtained where(A) iC3-Sepharose
positively charged or neutral side chains were replaced(B) C4b-Sepharose
with negatively charged ones, indicating that positiveOne representative measurement of two-to-four is shown by each
data point. In the case of C4b binding, mutants had binding values charge is favorable to binding. An interaction with a
of 6% compared to the parent fragment. Results are expressed dominant electrostatic component has been indicated
as a percentage of CR1 derivative bound to iC3-S or C4b-S of that previously by its salt dependency (Krych et al., 1994,
initially offered to the Sepharose. 1998; Krych-Goldberg et al., 1999), because positively
charged regions of other RCA proteins have been impli-
cated in binding to C3b/C4b (Kuttner-Kondo et al., 1996;
CCPs 1 and 2 of CR2 with C3d revealed details of that Blom et al., 2000) and due to the involvement of nega-
specific interaction, but there are no reports of cocrys- tively charged residues at the N terminus of C3b in inter-
tallization of RCA proteins with the less experimentally actions with RCA proteins (Oran and Isenman, 1999).
tractable C3b/C4b fragments. Attempts to examine CR1 Several nonconservative substitutions on the front
site 2-C3b interactions in the NMR tube by chemical face, however, have no effect on binding, implying that
shift mapping proved unsuccessful (data not shown), the interaction probably does not involve a contiguous
presumably due to the large size (180 kDa) and probable set of residues forming an intimate interface. This is
dimeric nature of C3b. Experiments using peptides that consistent with the dispersed (over several neighboring
are representative of C3b also failed (data not shown), modules) nature of the CR1-C3b/C4b interaction and its
probably due to low affinity. Therefore, the substantial low-to-medium affinity, i.e., 0.1–0.5 	M for the CR1/C4b
body of mutagenesis data for CR1 amassed over the interaction (Reilly and Mold, 1997) and 0.6 	M and 0.03
last ten years, when reconsidered in the light of the 	M for the C3b monomer and dimer, respectively (Weis-
current structure, provides the best insight yet into an man et al., 1990; Wong and Farrell, 1991). It is also
interaction between any member of the RCA family and comparable with the CR2-C3d interface revealed by
C3b/C4b. crystallography (Szakonyi et al., 2001) that shows a sig-
Figure 4 summarizes the mutagenesis data obtained nificant involvement of the peptide backbone in addition
so far. Not highlighted in Figure 4 is a triple mutation to a few side chain contacts involving positively charged
that gave some loss of C3b binding but where the side residues. Arg84 of CR2 occupies an anionic hole in C3d,
chains (944, 947, and 949) are dispersed on the surface; and Lys100 of CR2 participates in H2O-mediated H
drastic mutations in module 17 involving many residues bonds with C3d. Module 2 of CR2 and CCP 15 of CR1
(Krych et al., 1998) are also not shown. The majority of share 19 identical or conservatively replaced residues
and there are small insertions and deletions. The tworeported mutations of CR1 site 2 did not have a negative
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CCPs overlay reasonably well (1.7 A˚, using the C of confer good C3b binding activity on site 1. The equiva-
lent residues in functional site 2 are Tyr937, which con-22 residues). Equivalent residues to CR2’s Arg84 and
Lys100 are Lys914 and Arg933, both of which are critical tacts the linker residue Lys961, and Asp979, which is
also close to the 15,16 junction but on the other face toto the CR1-C3b interaction. Whether CR1 interacts with
the C3d portion of C3b as well as its N terminus is Tyr937. Indeed, Asp979 is on the back face of module
15, well away from amino acids identified as importantdebatable (Oran and Isenman, 1999; Cole et al., 1985).
Several residues on CCP 17 were also shown to be in C3b binding by mutagenesis of site 2. The difficulty
of rationalizing this important observation emphasizescritical for C3b/C4b binding. These appear not to lie
on the same face of site 2 as the functionally-critical the need for structure determination of site 1.
residues of CCPs 15 and 16, according to the preferred
orientation derived from NMR restraints (Figure 4). Given Conclusions
the likely loose nature of the 16,17 junction, module 17 This work provides the structural details of the much-
could swivel relative to module 16 in order to align its studied phenomenon of immune adherence first de-
binding face with that of 15,16. In support of this hypoth- scribed more than 100 years ago. It also provides the
esis, changes of residues at the 16,17 interface have 3D structure of a functional site from a mammalian regu-
little or no effect on C3b binding—for example, mutating lator of complement activation. It allows rationalization
the almost completely buried I1023 to Pro does not of extensive mutagenesis and functional data in the light
lower affinity for either protein, while mutation of sub- of a 3D structure. With the structure of site 2 in hand,
stantially buried Y1046 to Pro affects only C4b binding it will now be possible to pursue more mutagenesis
(Krych et al., 1998); it is unlikely that any functionally aimed at fine-mapping of the binding face, further dis-
critical preformed 16,17 orientation would survive these section of the C3b and C4b binding and cofactor activi-
substitutions, but a looser junction would be more toler- ties, and definition of the functional roles played by intra-
ant to substitutions provided they did not induce a differ- and intermodular flexibility. As a byproduct of this work,
ent preferred conformation. On the other hand, these a rational design of more selective inhibitors of comple-
two substitutions (I1023P and Y1046P) each have a dra- ment is possible. For example, a protein that binds C3b
matic effect on site 2’s activity as a cofactor for factor and inactivates alternative convertases but with no abil-
I-catalyzed proteolysis of C3b/C4b (Krych et al., 1998). ity to bind C4b and to inactivate classical convertases
Therefore, a specific kind of flexibility at the 16,17 junc- could be produced based on the mutagenesis of posi-
tion appears to be critical for this particular aspect of tively charged CCP 15 residues. Since site 2 has recently
site 2’s biological function. The mutation Y937S, close been shown to bind the P. falciparum protein PfEMP1
to the 15,16 junction, also reduces cofactor activity (Rowe et al., 2000), the design of selective inhibitors of
(Krych et al., 1994). this interaction, with therapeutic potential in malaria,
Unlike in previous work, these structure-guided muta- might also be feasible.
genesis experiments involved changes of residues that
Experimental Proceduresare conserved between sites 1 and 2. That residues
common to both sites are important is unsurprising,
Expression of Protein for NMR
since the activities of sites 1 and 2 overlap. Each site The three fragments of CR1—CR115–17 (modules 15–17, aa 901–
interacts with C3b and/or C4b and has both DAA and 1095 of the mature CR1), CR115,16 (modules 15 and 16, aa 901–
CA, albeit to very different degrees. It is likely that the 1024), and CR116,17 (modules 16 and 17, aa 961–1092)—were
expressed as described previously (Kirkitadze et al., 1999a). Theconserved amino acids identified here as functionally
sequence of each sample was preceded by EAEA—a remnant ofimportant in site 2 are also critical in site 1. Although
the signal peptide of the Pichia pastoris  factor. N glycosylationintermodular junctions and hence module-module orien-
sites were removed (module 15 mutation N918T, module 16 mutation
tations are probably not conserved between CCPs 15/ N987T).
16 (in site 2) and CCPs 1/2 (in site 1), mutations causing For preparation of 15N-labeled sample, yeast was grown in modi-
gain of function in site 1 (Krych et al., 1994, 1998; Subra- fied medium containing 0.34% yeast nitrogen base (YNB) without
aa and without (NH4)2SO4, supplemented with 1% (15NH4)2SO4. Formanian et al., 1996) may be interpreted cautiously in the
double-labeled samples, yeast was grown in modified medium con-light of the site 2 structure. An example of note is D109N
taining 0.34% YNB without aa and without (NH4)2SO4, supplemented(Krych et al., 1994, 1998). Asn1009, a homolog of D109
with 1% (15NH4)2SO4 and 0.25% 13C-glycerol in the preculture orin site 2, has no structural role, and if the same is true
0.25% 13C-methanol during the expression phase. For the (80%) 2H-
of D109, it implies C3b binding is enhanced by removing labeled sample, yeast was grown in glycerol-containing minimal
a negative charge or by adding the H bonding capabili- medium in which H2O was replaced with increasing concentrations
(from 40% to 80%) of 2 H2O.ties of an Asn. Another gain of function example is N29K.
A 0.6 mM (25 mM phosphate, 150 mM NaCl [pH 6.0]) sample ofThe equivalent site 2 residue is Lys929, and the reverse
2H (80%), 13C,15N-labeled CR115–17 yielded interpretable TROSY-mutation (K929N) causes only a small loss of C4b bind-
type spectra and was used to obtain backbone and C assignments.ing in site 2. Lys929 is located on the front face (down
Due to side chain deuteration, this sample was unsuitable for full
and to the left of Lys914 in Figure 4). The addition of a assignment or structure calculation based on 1H,1H NOEs. Therefore,
positive charge in this region of site 1 might enhance 13C,15N-labeled samples of overlapping module pairs CR115,16
and CR116,17 (1 mM, in 0.6 ml 20 mM potassium phosphate buffer,C3b binding, while on the other hand, the removal of a
20 mM NaCl [pH 6.0]) were used. Relaxation studies used 15N-labeledpositive charge from the front face of site 2 may not be
samples of CR115,16 and CR116,17 in the same buffer and atso important due to compensation by other basic side
the same concentration.chains. A striking gain of function arises from the double
substitution of S37Y in CCP 1 and G79D in CCP 2 (Subra- Data Collection/Processing
manian et al., 1996). When made individually these For the 2H (80%), 13C,15N-sample TROSY-versions (Salzmann et al.,
1999) (at 37C) of the HN(CA)CO and HNCACB experiments werechanges have only negligible effects, but together they
Cell
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collected at 800 MHz, and HNCO, HN(CO)CACB, HNCOCA, and 112.45 ms were utilized for measurement of T2. For both proteins a
reference 1H-15N NOE experiment was recorded with 5 s relaxationHNCA experiments were performed at 600 MHz. The following were
used for the resonance assignment of the module pairs (37C, 600 delay. A second 1H-15N NOE spectrum was recorded with saturation
of 1H achieved by a train of 1H 120 pulses applied for the last 3 sMHz unless stated otherwise): 1H,15N heteronuclear single-quantum
coherence (HSQC) spectra (Mori et al., 1995) and 3D experiments of the 5 s delay. Spectra were processed within AZARA and assigned
according to 15N,1H s of relevant HSQC spectra using ANSIG. AHNCACB, CBCA(CO)NH (Muhandiram and Kay, 1994), HNCO (Kay
et al., 1994), HN(CA)CO (Engelke and Ruterjans, 1995), HCC(CO)NH- single exponential decay was fitted to the extracted peak heights
for each residue to obtain the relaxation rates using nonlinear fitting.TOCSY (Grzesiek and Bax, 1992; Logan et al., 1993), HCCH3-TOCSY
(Uhrı´n et al., 2000), (HB)CB(CGCDCE)HE, and (HB)CB(CGCD)HD (Ya-
mazaki et al., 1993). A total correlation spectroscopy experiment Residual Dipolar Couplings
(HCCH-TOCSY) (Kay et al., 1993) and 15N- and 13C-edited NOESYs 15N-1H RDCs were measured for a 0.3 mM sample of 15N-labeled
(Pascal et al., 1994) were collected for each sample. In both cases, CR115,16 in 2% cetylpyridinium bromide/hexanol with a residual
the 15N-NOESY data were collected on the 15N-labeled sample. The 2H splitting of 3.1 Hz and for a similar, nonaligned sample using
13C-NOESY spectra were collected on a 800 MHz spectrometer. an IPAP pulse sequence (Ottiger et al., 1998). A total of 94 residual
Slowly exchanging amide protons (1.0 s1) were identified by dipolar couplings (RDCs) were extracted. The RDCs of residues
analysis of 2D heteronuclear water-exchange experiments (Mori et considered to be mobile (low 1H,15N NOE or in slow exchange) were
al., 1997). Partners for slowly exchanging protons were identified then eliminated, leaving 55 RDCs (25 in CCP 15, 30 in CCP 16) as
based on well-determined initial structures, supporting NOE data, input for subsequent calculations. Magnitudes and orientations of
and by consideration of the likely geometry of the putative H bond. the alignment tensors were calculated for CCPs 15 and 16 indepen-
Donor hydrogen-acceptor angles were constrained by appropriate dently from each of the structures in the ensemble (Losonczi et al.,
distance restraints (Nilges et al., 1997). A semiconstant time HMSQC 1999).
(Aitio and Permi, 2000) experiment was used to derive 3JHN-HA values.
The raw NMR data were processed within AZARA (http://www.bio. Constructs for Functional Assays
cam.ac.uk/azara/). Mutations were made using QuikChangeTM site-directed mutagene-
sis kit (Stratagene, La Jolla, CA). A modified LHR C (i.e., modules
15–21) (Krych et al., 1994) with site 2 identical to that used in NMRResonance Assignment—Structure Calculation
studies (no N glycosylation sites at N918 and N987) was used as aSpectra were viewed and atoms were assigned within ANSIG
template for mutagenesis. Plasmid pSG5 (Stratagene) containing(Kraulis, 1989). Completely resolved 15N-NOESY and 13C-NOESY
cDNA for LHR C or its derivatives was transfected into 293T humancrosspeaks were picked and assigned unambiguously wherever
kidney cells (Smith et al., 2000) using LipofectAMINE (Life Technolo-possible. The “connect” program within AZARA converted normal-
gies, Inc.) as described (Krych-Goldberg et al., 1999). Binding andized peak intensities into four distance categories of 2.7 A˚, 3.3 A˚,
cofactor assays were performed as described (Krych et al., 1994).5 A˚, and 6 A˚. Two separate lists, one of unambiguous NOE restraints,
the other of ambiguous restraints (with possibilities generated from
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